Repligen Corporation will acquire BioLife Solutions for 1.5 billion dollars in cash and stock, expanding its position in the fast-growing cell therapy manufacturing market.
The Trump administration Section 122 tariffs expire July 24, but Allianz Research warns Section 301 and Section 338 replacements will push average US import tariffs to 12.4 percent.
Kansas City Royals captain Salvador Perez hit his 317th career home run to tie Hall of Famer George Brett for the franchise record as the Royals beat the Giants 5-4.
The Canadian pension giant and global asset manager are taking private one of America's largest warehouse and logistics portfolios in an all-cash transaction.
The White House invoked a rarely-used century-old trade law to slap 50 percent tariffs on Canadian imports, prompting warnings of massive economic uncertainty.
The San Diego Padres superstar crushed a 474-foot moonshot in Atlanta, the longest homer of the MLB season, as San Diego dominated the Braves 8-3.
The largest M&A deal by a Korean biotech company positions Samsung to capitalize on the booming GLP-1 obesity drug market.
The latest FedViews report shows PCE inflation at 4.1 percent, with markets now pricing in interest rate increases for the second half of 2026.